Evidence map›Paper›PMID 42556850›Full record

ArticleEuropean respiratory review : an official journal of the European Respiratory Society2026

Patient-reported outcome measures applied in chronic diseases relevant to asthma remission: a scoping review.

Allison Michaud, John Politis, Lachlan Faktor, Philip G Bardin, Amy H Y Chan, Paul Leong

Abstract readScoping Review
In one paragraph

Article in European respiratory review : an official journal of the European Respiratory Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Allison MichaudDivision of Respiratory Medicine, Department of Medicine, University of Calgary, Calgary, AB, Canada allison.michaud@ahs.ca.ORCID https://orcid.org/0009-0008-4814-5766
John PolitisMonash Lung Sleep Allergy and Immunology and School of Clinical Sciences, Monash Health and Hudson Institute of Medical Research, Monash University, Melbourne, Australia.
Lachlan FaktorMonash Lung Sleep Allergy and Immunology and School of Clinical Sciences, Monash Health and Hudson Institute of Medical Research, Monash University, Melbourne, Australia.
Philip G BardinMonash Lung Sleep Allergy and Immunology and School of Clinical Sciences, Monash Health and Hudson Institute of Medical Research, Monash University, Melbourne, Australia.
Amy H Y ChanSchool of Pharmacy, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand.ORCID https://orcid.org/0000-0002-1291-3902
Paul LeongMonash Lung Sleep Allergy and Immunology and School of Clinical Sciences, Monash Health and Hudson Institute of Medical Research, Monash University, Melbourne, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAsthma remission is a meaningful treatment goal that requires patient and healthcare provider agreement. However, there is currently no validated way to incorporate patient perspectives of remission in this process. Patient-reported outcome measures (PROMs) can allow comprehensive assessment of remission by capturing the impact on individual patient experiences. The aim of this study was to identify PROMs used to define remission in other chronic diseases, thereby informing development of a PROM for asthma remission.

methodsA scoping review of primary research studies was conducted using five databases. Eligible studies reported on the development or validation of PROMs that assess remission in chronic diseases. Data were extracted and analysed thematically to identify types of PROMs, health domains assessed and methodological quality.

resultsNine studies met inclusion criteria, covering 12 PROMs for diseases such as rheumatoid arthritis, inflammatory bowel disease and ankylosis spondyloarthritis. Domains most frequently assessed included disease-specific symptoms (n=11), generalised symptoms (n=5) and mental health (n=2). PROMs generally asked patients about their current health (n=8) although some PROMs had longer recall periods (n=4). Only one PROM was developed with direct patient involvement.

conclusionsPROMs currently employed in other chronic diseases signify significant complexity when attempting to capture multidimensional aspects of disease remission from a patient perspective. However, fundamental domains and other health elements can be distinguished that will aid development of robust, patient-informed PROMs that align with patient-centred experiences of remission, thereby improving shared decision-making in asthma.

Indexed as

Anti-Asthmatic AgentsAsthmaPatient Reported Outcome MeasuresChronic DiseaseHealth StatusHumansPredictive Value of TestsQuality of LifeRemission InductionTreatment OutcomeAnti-Asthmatic Agents

Identifiers

PMID42556850
PMCPMC13439356

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.